EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics database

Tokimasa Hida

International Journal of Clinical Oncology · 2025

DOI: 10.1007/s10147-025-02755-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Clinical Oncology, 2025. Verfasst von Tokimasa Hida. Beteiligte Einrichtung: Department of Dermatology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-Ku, Sapporo, 060-8543, Japan. hidat@sapmed.ac.jp. Hauptthemen laut MEDLINE: Skin Neoplasms, Precision Medicine, Melanoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Maruho Takagi Dermatology Foundation, Suhara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors and molecular-targeted therapies have dominated recent cancer treatment. However, these treatments face challenges, such as primary and acquired resistance, indicating that not all patients benefit from them. Therefore, the search for new molecular targets is crucial. In addition, immune checkpoint inhibitors have exhibited racial differences in their effectiveness for certain neoplasms. Hence, understanding the genomic landscape of cancers in various racial groups is important. In Japan, health insurance has covered comprehensive genomic profiling since 2019, and the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) has accumulated genetic abnormalities along with clinical data of patients with various cancers. These data are crucial for advancing cancer research and drug development. This review discusses the genetic abnormalities of the major skin malignancies including melanoma, cutaneous squamous cell carcinoma (cSCC), and extramammary Paget's disease (EMPD), and proposes potential treatment strategies by comparing C-CAT data analysis with other genetic studies. The C-CAT data have emphasized unique genetic alterations in tumors of the Japanese population, particularly racial differences in tumor mutational burden in cutaneous melanoma and cSCC, indicating the importance of personalized treatment strategies that consider racial differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsPrecision MedicineMelanomaHumansGenomicsMolecular Targeted TherapyJapanMutationCarcinoma, Squamous Cell

Stichwörter der Autor:innen

Extramammary Paget’s diseaseImmune checkpoint inhibitorsMelanomaMolecular-targeted therapyMutationSquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Dermatology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-Ku, Sapporo, 060-8543, Japan. hidat@sapmed.ac.jp.

Förderung

  • Japan Society for the Promotion of Science
  • Maruho Takagi Dermatology Foundation
  • Suhara Memorial Foundation

Zitieren

APA

Hida, T. (2025). Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics database. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-025-02755-9

Vancouver

Hida T. Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics database. International Journal of Clinical Oncology. 2025. doi:10.1007/s10147-025-02755-9

BibTeX
@article{Hida2025,
  author = {Hida, Tokimasa},
  title = {Genomic profiling and personalized treatment strategies for skin malignancies: findings from the center for cancer genomics and advanced therapeutics database},
  journal = {International Journal of Clinical Oncology},
  year = {2025},
  doi = {10.1007/s10147-025-02755-9}
}
Kostenlos starten →